Karyopharm Therapeutics Inc. (KPTI)
NASDAQ · Healthcare
Karyopharm Therapeutics Inc. Net Income 2011–2025
Karyopharm Therapeutics Inc. annual/quarterly net income history and growth rate from 2012 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Karyopharm Therapeutics Inc. net income for the quarter ending March 31, 2026 was -22.4 M, a 4.56% decrease year-over-year.
- Karyopharm Therapeutics Inc. net income for the twelve months ending March 31, 2026 was -116.2 M, a 45.02% increase year-over-year.
- Karyopharm Therapeutics Inc. annual net income for 2025 was -196.0 M, a 156.52% increase from 2024.
- Karyopharm Therapeutics Inc. annual net income for 2024 was -76.4 M, a 46.60% decrease from 2023.
- Karyopharm Therapeutics Inc. annual net income for 2023 was -143.1 M, a 13.43% decrease from 2022.
- Karyopharm Therapeutics Inc. annual net income for 2022 was -165.3 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Karyopharm Therapeutics Inc. Net Income — FAQ
Karyopharm Therapeutics Inc. (KPTI) net income over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
What is Karyopharm Therapeutics Inc.'s net income?
Karyopharm Therapeutics Inc. (KPTI) reported net income of -$196M for fiscal 2025.
Where can I see KPTI's net income history?
The chart and table above show Karyopharm Therapeutics Inc.'s net income by year and by quarter, including the growth rate.